Wird geladen...
Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
The introduction of a direct-acting antiviral (DAA) for patients with hepatitis C virus (HCV) infection, could lead to higher sustained virologic response (SVR) rates with fewer adverse events, and it could shorten the treatment duration relative to the interferon era. Although most recent clinical...
Gespeichert in:
| Veröffentlicht in: | World J Hepatol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Baishideng Publishing Group Inc
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6323517/ https://ncbi.nlm.nih.gov/pubmed/30631394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v10.i12.898 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|